Dr. Kris on Personalizing Therapy in Lung Cancer

Mark G. Kris, MD
Published: Tuesday, Mar 19, 2019



Mark G. Kris, MD, medical oncologist, William and Joy Ruane Chair in Thoracic Oncology, Memorial Sloan Kettering Cancer Center, discusses personalizing therapy in the treatment of patients with lung cancer.

With all the advances made in lung cancer in 2018, it is critical to consider every therapeutic option available for each specific disease subtype and each individual patient. Having a rigid standard of care for each line of treatment would be doing a disservice to the patient, Kris says. Instead, a more individualized treatment approach would be most effective for that patient.

Furthermore, there should be a multimodality approach at every decision point in treatment, he adds. Some patients progress on checkpoint inhibitors with oligometastatic disease that can be resected or ablated, instead of needing to move on to another line of chemotherapy. The same is true for patients with oncogene-driven disease who are treated with TKIs.
SELECTED
LANGUAGE


Mark G. Kris, MD, medical oncologist, William and Joy Ruane Chair in Thoracic Oncology, Memorial Sloan Kettering Cancer Center, discusses personalizing therapy in the treatment of patients with lung cancer.

With all the advances made in lung cancer in 2018, it is critical to consider every therapeutic option available for each specific disease subtype and each individual patient. Having a rigid standard of care for each line of treatment would be doing a disservice to the patient, Kris says. Instead, a more individualized treatment approach would be most effective for that patient.

Furthermore, there should be a multimodality approach at every decision point in treatment, he adds. Some patients progress on checkpoint inhibitors with oligometastatic disease that can be resected or ablated, instead of needing to move on to another line of chemotherapy. The same is true for patients with oncogene-driven disease who are treated with TKIs.



View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Online Medical Crossfire®: 5th Annual Miami Lung Cancer ConferenceMay 30, 20196.5
Community Practice Connections™: Working Group for Changing Standards in EGFR-Mutated Lung Cancers: Real-World Applications of the Evidence for NursesJun 29, 20191.5
Publication Bottom Border
Border Publication
x